Bayer receives FDA approval for HIV viral load test
BY Advocate.com Editors
September 20 2002 12:00 AM ET
Officials at drugmaker Bayer this week announced that the company has received Food and Drug Administration approval to market a test that can detect the blood-based viral loads of all major strains of HIV. The test, called Versant HIV-1 RNA 3.0 Assay, detects viral genetic material in the blood and can be used worldwide because it can identify HIV RNA from all major subtypes of the virus. HIV viral load measurements are key indicators of HIV disease progression and of the effectiveness of antiretroviral therapy treatment. HIV-positive patients taking anti-HIV drugs should have regular viral load tests to ensure that their combination therapy is effectively suppressing viral replication.
- Op-ed: 'Religious Discrimination' Laws Have Nothing to Do With Religion
- Indiana Newspaper Sends Big Message
- These Indiana Businesses Haven't Weighed in on Discrimination
- Subaru Comes Out Against Indiana's 'License to Discriminate'
- Arrow and The Flash Stars: It's Time for a Gay Superhero on TV
- Gov. Mike Pence: 'This Is a Perception Problem'